Covered recipient · General Payments record
DESIREE CASASNOVAS-LOPEZ
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018–2024
$1,381.95
- Reported across 58 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $640.90 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $199.02 | 10 |
| EISAI INC. | $177.77 | 3 |
| Amneal Pharmaceuticals LLC | $42.08 | 2 |
| Neurocrine BioSciences, Inc. | $41.90 | 2 |
| Genentech USA, Inc. | $37.73 | 2 |
| Lilly USA, LLC | $35.39 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $25.91 | 1 |
| MDD US Operations, LLC | $24.74 | 1 |
| PFIZER INC. | $23.72 | 1 |
| Lundbeck LLC | $19.49 | 1 |
| Teva Pharmaceuticals USA, Inc. | $13.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $23.84 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424677 | CMS |
| ABBVIE INC. | $28.75 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424679 | CMS |
| ABBVIE INC. | $13.10 | 04/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424681 | CMS |
| ABBVIE INC. | $7.18 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424683 | CMS |
| ABBVIE INC. | $23.84 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424685 | CMS |
| ABBVIE INC. | $22.47 | 08/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424687 | CMS |
| ABBVIE INC. | $25.52 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424689 | CMS |
| ABBVIE INC. | $15.67 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424691 | CMS |
| ABBVIE INC. | $18.25 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424693 | CMS |
| ABBVIE INC. | $20.40 | 11/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103424695 | CMS |
| Amneal Pharmaceuticals LLC | $18.33 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139182111 | CMS |
| Amneal Pharmaceuticals LLC | $23.75 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139182113 | CMS |
| Eisai Inc. | $24.10 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741645 | CMS |
| Eisai Inc. | $124.25 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741641 | CMS |
| Eisai Inc. | $29.42 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110741643 | CMS |
| Genentech USA, Inc. | $14.77 | 04/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133001326 | CMS |
| Genentech USA, Inc. | $22.96 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133001331 | CMS |
| Lilly USA, LLC | $16.07 | 02/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136143577 | CMS |
| Lilly USA, LLC | $19.32 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136141061 | CMS |
| Lundbeck LLC | $19.49 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145903180 | CMS |
| MDD US Operations, LLC | $24.74 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147762559 | CMS |
| Neurocrine Biosciences, Inc. | $16.82 | 06/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150869580 | CMS |
| Neurocrine Biosciences, Inc. | $25.08 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1150839612 | CMS |
| Novartis Pharmaceuticals Corporation | $25.91 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086757445 | CMS |
| PFIZER INC. | $23.72 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131554497 | CMS |
| Teva Pharmaceuticals USA, Inc. | $13.15 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151586976 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.